BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytomX Therapeutics, Inc. 

650 Gateway Boulevard
Suite 125
South San Francisco  California  94080-7014  U.S.A.
Phone: 650-515-4987 Fax: 650-351-0353


SEARCH JOBS




Industry
Biotechnology






 Company News
South San Francisco's CytomX Therapeutics, Inc. Inks Potential $348 Million Cancer-Fighting Deal With Bristol-Myers Squibb Company (BMY) 5/27/2014 6:25:35 AM
CytomX Therapeutics, Inc. To Present Data From Anti-Jagged Probody Program At Upcoming American Association for Cancer Research Annual Meeting 2014 3/26/2014 7:25:39 AM
CytomX Therapeutics, Inc. and ImmunoGen, Inc. (IMGN) Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets 1/9/2014 7:56:38 AM
CytomX Therapeutics, Inc. Presents Data for First-in-Class Jagged Probody™ Program at American Association for Cancer Research-American Association for Cancer Research-EORTC International Conference 10/23/2013 7:02:18 AM
CytomX Therapeutics, Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2013 6:28:03 AM
CytomX Therapeutics, Inc.Announces Appointment of Krishna Polu, M.D., as Chief Medical Officer; Promotion of Debanjan Ray, MBA, to Vice President, Business Development 7/16/2013 10:21:05 AM
Pfizer Inc. (PFE), SF-Based CytomX Therapeutics, Inc. Ink $635 Million Oncology Deal 6/6/2013 7:41:02 AM
CytomX Therapeutics, Inc. Named a 2013 Red Herring Top 100 North America Tech Startup 6/3/2013 11:00:52 AM
CytomX Therapeutics, Inc. Expands Series B Financing; Canaan Partners Joins Syndicate 7/31/2012 10:00:20 AM
CytomX Therapeutics, Inc. Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors 3/6/2012 6:26:36 AM
12